The possible interactions between serotonergic and glutamatergic systems during neural development and under the pathogenesis of depression remain unclear. We now investigated roles of 5-HT 1A receptor in the mRNA expression of AMPA receptor subunits (GluR1 and GluR2) and brain-derived neurotrophic factor (BDNF) using primary culture of cerebral cortex of mouse embryos. Neurons at embryonic day 18 were cultured for 3 days or 14 days and then treated with 5-HT 1A receptor agonist (8-OH-DPAT) for 3 h or 24 h. In neurons cultured for 3 days, 8-OH-DPAT treatment for both 3 h and 24 h increased the mRNA levels of BDNF and GluR1, but not GluR2. In neurons cultured for 14 days, however, 8-OH-DPAT had no effects on these mRNA levels. Next, we examined in vivo roles of 5-HT 1A receptor by administration of 8-OH-DPAT to newborn mice. Twenty-four hours after the oral administration of 8-OH-DPAT, the mRNA expression of BDNF was decreased in the frontal cortex, but had no effects on the mRNA expression of GluR1 and GluR2. Taken together, the present study suggests that 5-HT 1A receptor activation modulates mRNA expression of AMPA receptor subunit and BDNF in cortical neurons, and the effects are different between in vitro and in vivo.
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Introduction
Serotonin (5-hydroxytryptamine, 5-HT) is a monoamine with multiple physiological functions. The early appearance of 5-HT neurons and 5-HT receptors in the embryonic brain (Lidov and Molliver, 1982a,b; Wallace and Lauder, 1983; Lauder, 1990) suggests that 5-HT plays crucial roles in the neural development (Gaspar et al., 2003; Wirth et al., 2016) . In addition, disorder of 5-HT system is closely related to neuropsychiatric diseases. For example, depression is hypothesized to be caused by altered levels of 5-HT (Artigas, 2013; Dale et al., 2015) E-mail address: tshiga@md.tsukuba.ac.jp (T. Shiga). Celada et al., 2013) . Among these receptors, 5-HT 1A receptor appears in the early embryonic brain and regulates various aspects of neural development (Bonnin et al., 2006) . In the matured brain, 5-HT 1A receptor acts as presynaptic autoreceptor in 5-HT neurons of the raphe nuclei and postsynaptic heteroreceptor in many brain regions including the cerebral cortex, hippocampus and amygdala (Artigas, 2013; Fiorino et al., 2014) . Human studies of postmortem patients (López-Figueroa et al., 2004; Szewczyk et al., 2009 ) and by positron emission tomography (Bhagwagar et al., 2004; Drevets et al., 2007) as well as preclinical studies using experimental animals (Haddjeri et al., 1998; Scorza et al., 2012) have demonstrated that 5-HT 1A receptor in the cerebral cortex is involved in action of antidepressants. Recently, a number of studies have shown that glutamatergic system may be a novel target for treatment of major depressive disorder (MDD). ˛-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor is likely to be involved in actions of antidepressants. AMPA receptor consists of tetramers composed of four subunits, GluR1-GluR4. Among these subunits, only GluR2 lacks Ca 2+ permeability, which gives diverse properties to AMPA recephttp://dx.doi.org/10.1016/j.neures.2016.09.008 0168-0102/© 2016 Elsevier Ireland Ltd and Japan Neuroscience Society. All rights reserved.
